The Relationship of Neoadjuvant Taxanes, Anthracyclines, Cyclophosphamide Chemotherapy on Nutritional Status Based on Body Mass Index (BMI) and Albumin Measurements in Locally Advanced Stage Breast Cancer Patients in Bahteramas Hospital Kendari
Abstract
Background: Breast cancer is a disease caused by cancer cells in breast tissue. The most frequently found is locally advanced. The locally advanced stage refers to stages IIIA, IIIB, and IIIC. Neoadjuvant is the treatment for locally advanced. The Taxane, Anthracycline, and Cyclophosphamide (TAC) is a neoadjuvant chemotherapy regimen that can cause nausea and vomiting resulting in decreased appetite and lack of nutritional intake in patients. This study aims to determine the relationship between neoadjuvant TAC chemotherapy and nutritional status based on measurements of BMI and albumin in breast cancer patients at Bahteramas Kendari Hospital.
Method: This study was conducted with a retrospective cross-sectional design. The sampling technique was consecutive sampling using 41 medical records of breast cancer patients from the years 2023 to 2024 in Bahteramas Kendari Hospital.
Result: There were significant changes in the nutritional status of patients who received neoadjuvant TAC chemotherapy. Before chemotherapy, the patient’s BMI was found to be in the normal category of 34.1% and decreased to 31.7% after chemotherapy. Likewise, patients with obesity were 34.1% before chemotherapy and changed to 19.5% after chemotherapy. Furthermore, there were significant changes in the patient’s albumin levels. Before chemotherapy, 38 patients had normal albumin levels (92.7%), whereas after chemotherapy only 24 patients had normal albumin levels (58.5%).
Conclusion: There was a relationship between TAC neoadjuvant chemotherapy and nutritional status based on BMI and Albumin measurements before and after chemotherapy in patients with locally advanced breast cancer.
Keywords
DOI: 10.33371/ijoc.v18i4.1283
Article Metrics
Abstract View: 404, 
PDF Download: 246
References
Andriansyah D, Eka Wulansari Fridayanthie. Optimization of Support Vector Machine and XGBoost Methods Using Feature Selection to Improve Classification Performance. Journal of Informatics and Telecommunication Engineering. 2023 Jan 25;6(2):484–93.
Giovanno A, Qodir N, Umar M. Neoadjuvant Chemotherapy Response to Local Advanced Breast Cancer Patients at Dr Mohammad Hoesin Hospital Palembang. Sriwijaya Journal of Medicine. 2020;
Huang X, Li X, Li J, Luo L, Chen H, Tan Y, et al. Chemotherapy-Induced Nausea and Vomiting in Breast Cancer Patients: A Multicenter Prospective Observational Study. Asia Pac J Oncol Nurs. 2021 Jul 1;8(4):433–7.
Dranitsaris G, Molassiotis A, Clemons M, Roeland E, Schwartzberg L, Dielenseger P, et al. The development of a prediction tool to identify cancer patients at high risk for chemotherapyinduced nausea and vomiting. Annals of Oncology. 2017 Jun 1;28(6):1260–7.
Sheas MN, Ali SR, Safdar W, Tariq MR, Ahmed S, Ahmad N, et al. Nutritional Assessment in Cancer Patients. Cancer Treat Res. 2023;185:285–310.
Rachma A, Darmawan F, Adriani M. Nutritional Status, Energy and Macronutrient Intake of Cancer Patients undergoing Chemotherapy in Dr. Ramelan Naval Hospital Surabaya. Amerta Nutr. 2019;149–57.
Widhiarta KD, Askandar B. The correlation of nutritional status with hematology toxicity of adjuvant chemotherapy in ovarian cancer. Majalah Obstetri & Ginekologi. 2021 Sep 14;29(2):57.
Marinho E da C, Custódio IDD, Ferreira IB, Crispim CA, Paiva CE, Maia YC de P. Impact of chemotherapy on perceptions related to food intake in women with breast cancer: A prospective study. PLoS One. 2017 Nov 1;12(11).
de Souza BC, Silva GCF, Zangirolami-Raimundo J, Gardin O, Noll PRES, Carniel CF, et al. The influence of chemotherapy on nutritional status and oncological fatigue in cancer patients: Cross-sectional study. Journal of Human Growth and Development. 2024;34(1):95–103.
Pinto e Silva MP, Sunemi MM de O, Fretta T de B, Fernandes ACNL, Mascarenhas LR de S, Dias M, et al. Recommendations for Physiotherapy in Breast and Gynecological Cancer during COVID-19 Pandemic: Literature Review. Revista Brasileira de Cancerologia. 2021 Jun 10;67(2).
Van Den Berg M, Winkels R, Dik E, De Vries Y, De Kruif A, De Vries J, et al. The dietary intake of breast cancer patients during chemotherapy. Eur J Cancer. 2016;57(27).
Inglis JE, Lin PJ, Kerns SL, Kleckner IR, Kleckner AS, Castillo DA, Mustian KM, Peppone LJ. Nutritional Interventions for Treating Cancer-Related Fatigue: A Qualitative Review. Nutr Cancer. 2019;71(1):21-40.
Hidayat A, Eka Purwani L, Nugrohowati N. Relationship of Chemotherapy and Energy Intake with Nutritional Status of Breast Cancer Patients Stage II-III at Fatmawati General Hospital in 2018–2019. Media Gizi Indonesia. 2020;15(2):110–8.
Bicakli DH, Varol U, Degirmenci M, Tunali D, Cakar B, Durusoy R, et al. Adjuvant Chemotherapy May Contribute to an Increased Risk For Metabolic Syndrome in Patients With Breast Cancer. Journal of Oncology Pharmacy Practice. 2016;22(1).
Zainoel A. The Relationship of Serum Albumin Levels with Handgrip Strength on Cancer Patients in RSUD dr. Jurnal Ilmiah Mahasiswa Medisia. 2017;2(1):74–80.
Setiawati NC, Yudiyanta, Wibowo S. The effect of albumin levels on the severity of taxanes-induced peripheral neuropathy in breast cancer. Berkala Neuroscience. 2019;18.
Halwa S, Pramono JS, Reski S. Correlation of Chemotherapy Frequency with Albumin Levels and Weight Loss in Breast Cancer Patients at Abdoel Wahab Sjahranie Samarinda Regional General Hospital. Formosa Journal of Applied Sciences. 2023 Oct 31;2(10):2495–506.
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Email this article 
